![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Enrolling by invitation |
Unique ID issued by UMIN | UMIN000012462 |
Receipt No. | R000013012 |
Scientific Title | Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test. |
Date of disclosure of the study information | 2013/12/02 |
Last modified on | 2016/12/04 |
Basic information | ||
Public title | Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test. | |
Acronym | Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus. | |
Scientific Title | Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test. | |
Scientific Title:Acronym | Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus. | |
Region |
|
Condition | ||
Condition | Type 2 diabetes mellitus | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To verify the effects of bezafibrate and fenofibrate on peripheral insulin resistance by the glucose clamp technique and on postprandial glucose metabolism tby the meal tolerance test in Japanese patoents with type 2 diabetes mellitus. |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | Confirmatory |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Improvement of glucose infusion rate during euglycemic-hyperinsulinemic clamp and improvement of HbA1c and postprandial blood glucose. |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Open -no one is blinded |
Control | Active |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Bezafibrate
Fenofibrate |
|
Interventions/Control_2 | Bezafibrate was not administered.
Fenofibrate was not administered. |
|
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | HbA1c 6.0-9.0% | |||
Key exclusion criteria | Type 1 diabetes mellitus, pancreatic disease, liver disease, renal failure, or those taking diabetogenic medications such as corticosteroids | |||
Target sample size | 20 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Tottori University Faculty of Medicine | ||||||
Division name | Division of Cardiovascular Medicine, Endocrinology and Metabolism | ||||||
Zip code | |||||||
Address | Nishi-chou 36-1, Yonago, Tottori 683-8504, Japan. | ||||||
TEL | 0859-38-6517 | ||||||
ohkura@med.tottori-u.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Tottori University Faculty of Medicine | ||||||
Division name | Division of Cardiovascular Medicine, Endocrinology and Metabolism | ||||||
Zip code | |||||||
Address | Nishi-chou 36-1, Yonago, Tottori 683-8504, Japan. | ||||||
TEL | 0859-38-6517 | ||||||
Homepage URL | |||||||
hideki-shiochi.1028@beetle.ocn.ne.jp |
Sponsor | |
Institute | Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine |
Institute | |
Department |
Funding Source | |
Organization | Tottori University Faculty of Medicine |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Enrolling by invitation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013012 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |